Matches in Nanopublications for { ?s ?p "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP619252.RACN88AzSa1tkE1uS_6vAfX5uWcMPAzH3NDNpmx3K3lPY130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619252.RACN88AzSa1tkE1uS_6vAfX5uWcMPAzH3NDNpmx3K3lPY130_provenance.
- NP363424.RA6oXYy82sshyX7Zi5fyWgr5_ogauUduSE27Lgaq6p1bk130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363424.RA6oXYy82sshyX7Zi5fyWgr5_ogauUduSE27Lgaq6p1bk130_provenance.
- NP220324.RAlmHPJAzHMwfaJWzEWCeAc_j_VqBf9p1KbVOidRjHdVA130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220324.RAlmHPJAzHMwfaJWzEWCeAc_j_VqBf9p1KbVOidRjHdVA130_provenance.
- NP648706.RAXwOR8X9Nfh2LYeLXERVuDsZUYW4TGi04Agz27NSYpRg130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648706.RAXwOR8X9Nfh2LYeLXERVuDsZUYW4TGi04Agz27NSYpRg130_provenance.
- NP657381.RAZl_Idl6B9sTcyjwwa5wl6QZH8BOcrKj1VcCnTHDZhgA130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657381.RAZl_Idl6B9sTcyjwwa5wl6QZH8BOcrKj1VcCnTHDZhgA130_provenance.
- NP770706.RAiXZLao2RHyB_G2s7w0G65iAo8ja8PyfylAVZitWF678130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770706.RAiXZLao2RHyB_G2s7w0G65iAo8ja8PyfylAVZitWF678130_provenance.
- NP785469.RAXVsl21SpUVArvtHT_mM1yRjYRNlwBaCQX2snyhIEoes130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785469.RAXVsl21SpUVArvtHT_mM1yRjYRNlwBaCQX2snyhIEoes130_provenance.
- NP785466.RARjksSdcqHhiY_kDgGFDpHBwMhWrN-WjMbEs5Nzi8SIU130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785466.RARjksSdcqHhiY_kDgGFDpHBwMhWrN-WjMbEs5Nzi8SIU130_provenance.
- NP785467.RAfJZj6gFzsz7YXdqm7os85R3baWlwSIDku9rQ4hDF7Lw130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785467.RAfJZj6gFzsz7YXdqm7os85R3baWlwSIDku9rQ4hDF7Lw130_provenance.
- NP573278.RA8wWVC7r5MiR-fG9-zqDbUNvug_9IGzA0VeAhqq6Ddkc130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573278.RA8wWVC7r5MiR-fG9-zqDbUNvug_9IGzA0VeAhqq6Ddkc130_provenance.
- NP557654.RAxOySvtjoXCSaH2kHezjMiaPo6K7t1lpJdEa_HSBI1Mk130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557654.RAxOySvtjoXCSaH2kHezjMiaPo6K7t1lpJdEa_HSBI1Mk130_provenance.
- NP785468.RAN0dGaf8zimGnDHatTgAGpNplaOQkZYvGECOizHdX_Z0130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785468.RAN0dGaf8zimGnDHatTgAGpNplaOQkZYvGECOizHdX_Z0130_provenance.
- NP931348.RAyQYi5HOSRaem9lTTa83BA4nlrukFal5-IogqW5W6vuY130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931348.RAyQYi5HOSRaem9lTTa83BA4nlrukFal5-IogqW5W6vuY130_provenance.
- NP785465.RA1sitIY1id5zet0Gl9rQb2jG4v37zuI6N1eJp6Y8HWpQ130_assertion description "[The expression of COX-2, gamma-catenin, Topoisomerase IIa, VEGF and MIB-1 was significantly higher in the cohort of recurrent meningiomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785465.RA1sitIY1id5zet0Gl9rQb2jG4v37zuI6N1eJp6Y8HWpQ130_provenance.